Pharvaris N.V. Files Form 144 for Security Sale
Ticker: PHVS · Form: 144 · Filed: 2026-04-08T16:35:38-04:00
Sentiment: neutral
Topics: insider-filing, securities-sale, pharmaceutical
TL;DR
Pharvaris N.V. filing 144 - looks like they're selling stock.
AI Summary
On April 8, 2026, Pharvaris N.V. filed a Form 144, indicating a proposed sale of securities. The filing was made by Modig Berndt, associated with Axovant Sciences, Inc., with a mailing address at 1441 Broadway, 3rd Floor, New York, NY 10018. Pharvaris N.V. is a pharmaceutical company.
Why It Matters
This filing signals potential insider selling or a planned divestiture of shares by Pharvaris N.V., which could impact its stock price.
Risk Assessment
Risk Level: medium — Form 144 filings can indicate insider selling, which may precede a price drop, but the exact number of shares and value are not specified in this initial filing.
Key Players & Entities
- Pharvaris N.V. (company) — Subject company
- Modig Berndt (person) — Reporting person
- Axovant Sciences, Inc. (company) — Associated company
- 2026-04-08 (date) — Filing date
FAQ
What is the purpose of a Form 144 filing?
A Form 144 filing is a notice of proposed sale of securities, typically by an insider or affiliate of a company, and is required when a certain volume of shares is to be sold.
Who is filing this Form 144?
The filing is associated with Pharvaris N.V. and mentions Modig Berndt in relation to Axovant Sciences, Inc.
When was this Form 144 filed?
The Form 144 was filed on April 8, 2026.
What is Pharvaris N.V.'s business?
Pharvaris N.V. is identified as being in the Pharmaceutical Preparations industry (SIC 2834).
Are the specific number of shares or dollar amounts for the proposed sale detailed in this filing?
This specific filing (Accession No. 0001950047-26-003332) does not appear to contain the specific number of shares or dollar amounts for the proposed sale, as it is a notification of intent.
From the Filing
EDGAR Filing Documents for 0001950047-26-003332 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 144 - Report of proposed sale of securities: SEC Accession No. 0001950047-26-003332 Filing Date 2026-04-08 Accepted 2026-04-08 16:35:38 Documents 1 Document Format Files Seq Description Document Type Size 1 primary_doc.html 144 1 primary_doc.xml 144 3538 Complete submission text file 0001950047-26-003332.txt 5145 Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018 Business Address Modig Berndt ( Reporting ) CIK : 0001643072 (see all company filings) Type: 144 Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN Netherlands Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN Netherlands 31 (0)71 203 6410 Pharvaris N.V. (Subject) CIK : 0001830487 (see all company filings) EIN. : 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231 Type: 144 | Act: 33 | File No.: 001-40010 | Film No.: 26848573 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)